Vabion Scientist To Speak On Chemo Brain

Cancer survivor recovered from debilitating side effect

by Susan Hardwicke

(WireNews+Co) - Richmond, V.A, USA - 31 August 2009

VABION LLC (VABION) announced today that VABION chief executive and chief scientist Susan Hardwicke, Ph.D., will present a workshop titled “Chemo Brain and Recovery” at the 2009 Virginia Blood Cancer Conference on September 26, 2009, in Richmond, Virginia.  Created and presented by the Virginia Chapter of the Leukemia and Lymphoma Society, the conference is an annual event for blood cancer patients, survivors, parents, caregivers, oncology nurses, and social workers.  Dr. Hardwicke is a Stage III breast cancer survivor whose experience in recovering from chemo brain inspired the creation of a program designed to help survivors and professionals.

“I experienced cancer treatment and chemotherapy as a patient, and had excellent care from all of the professionals who treated me.  However, the brain-damaging side effects of chemotherapy effects, such as chemo brain, weren’t well recognized at the time.  I paid a high price for that lack of knowledge,” Dr. Hardwicke said.   Memory impairment, speech difficulties, slowed reaction time, and decision-making were among the problems she encountered after beginning chemotherapy treatments.

Dr. Hardwicke, author of an eBook on Chemo Brain, will present an overview of research on chemo brain, a summary of the Chemo Brain Recovery program she developed, and descriptions of her experience as she recovered.   The program involves nutrition, mental and physical exercise, and emotional and spiritual growth, as well as new evidence about reducing anxiety and fog associated with chemo brain.

About VABION LLC

VABION LLC is a Virginia-based company that develops research-based innovative nutraceutical products that improve energy, and the physical and mental performance of the brain.  Susan Hardwicke, Ph.D., founded the company in 2006 to develop products based on her own research on RNA and other energy supplements. The Company's products are distributed through vitamin retail stores, chain drug stores, specialty stores, gyms, convenience stores, online supplement stores, and its e-commerce website. Additional information is available at www.vabion.com (http://www.vabion.com) and www.healthafterchemo.com (http://www.healthafterchemo.com).

About the Leukemia and Lymphoma Society

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. LLS's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, LLS has invested more than $600 million in research specifically targeting blood cancers.

In 2009, The Leukemia & Lymphoma Society (LLS) celebrates its 60th anniversary and its commitment to curing blood cancers and helping patients and their families.

"The Leukemia & Lymphoma Society is celebrating 60 years of helping patients live better, longer lives. We are, and always will be, committed to our critical mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families,” said John E. Walter, President and CEO, at the Society’s Annual Strategic Leadership Conference in November 2008.  Additional information is available at www.lls.org (http://www.lls.org).